BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 20637864)

  • 1. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
    Stadelmann C; Wegner C; Brück W
    Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
    Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
    Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages and neurodegeneration.
    Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
    Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
    Peterson LK; Fujinami RS
    J Neuroimmunol; 2007 Mar; 184(1-2):37-44. PubMed ID: 17196667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Sclerosis Pathology.
    Lassmann H
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 29358320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and disease mechanisms in different stages of multiple sclerosis.
    Lassmann H
    J Neurol Sci; 2013 Oct; 333(1-2):1-4. PubMed ID: 23735777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of demyelinating diseases.
    Popescu BF; Lucchinetti CF
    Annu Rev Pathol; 2012; 7():185-217. PubMed ID: 22313379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.
    Centonze D; Muzio L; Rossi S; Furlan R; Bernardi G; Martino G
    Cell Death Differ; 2010 Jul; 17(7):1083-91. PubMed ID: 19927157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.
    Filippi M; Rocca MA
    J Neurol; 2005 Nov; 252 Suppl 5():v16-24. PubMed ID: 16254697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
    Witte ME; Mahad DJ; Lassmann H; van Horssen J
    Trends Mol Med; 2014 Mar; 20(3):179-87. PubMed ID: 24369898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v10-5. PubMed ID: 16254696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the neuropathology of multiple sclerosis.
    Stadelmann C
    Rev Neurol (Paris); 2007 Jun; 163(6-7):657-61. PubMed ID: 17607185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.